http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H04279522-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a0f654adc4ee9bbbfeb9c13d1ebd016a
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-07
filingDate 1991-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56bcb13e05703f5174f819cc2c4c71e8
publicationDate 1992-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H04279522-A
titleOfInvention Medicine for regulating serum calcium concentration
abstract PURPOSE: To provide the title medicine easy to handle by patients themselves, effective for the prevention or therapies of hypercalcemia and hypocalcemia, in particular, for suppressing rapid rise in serum calcium level due to vitamin D administration. n CONSTITUTION: The objective medicine containing either (A) vitamin A or (B) a mixture of vitamin A with vitamin D (pref. vitamin D 2 and/or vitamin D 3 ) at the weight ratio D/A=pref. (1:1.6) to (1:10000) (in the case of (B), pref. further containing calcium). For the therapy of hypercalcemia, vitamin A is only to be administered singly; thereby, serum calcium concentration can be reduced relatively easily and safely. For the therapy of hypocalcemia, vitamin A should be administered in combination with vitamin D; thereby, rapid rise in serum calcium concentration will be suppressed and side effects are prevented; therefore, vitamin D can be conveniently administered without the need for strictly controlling serum calcium level. n COPYRIGHT: (C)1992,JPO&Japio
priorityDate 1991-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445354
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226509607
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395603
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551033
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71308193
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426079173
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553004
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395601
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395383
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5354043
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406009
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552862
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406008
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280795
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559505
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87058084
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12303103
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395371
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87070941
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280793

Total number of triples: 36.